Overview Financials News + Filings Key Docs Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
IM Cannabis Corp. (IMCC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
6-K
| Quarterly results |
| 10/10/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 10/03/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 09/29/2023 |
6-K
| Quarterly results |
| 08/14/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Company" or "IMC",
"IM CANNABIS CORP. AND ITS SUBSIDIARIES NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS",
"Review: I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance...",
"Review: I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended June 30, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performance...",
"SCHEDULE A: FINANCIAL STATEMENTS Financial statements are required as follows: For the first, second and third financial quarters interim financial statements prepared in accordance with the requirements under Ontario securities law must be attached. If the Issuer is exempt from filing certain interim financial statements, give the date of the exempting order. FORM 5 – QUARTERLY LISTING STATEMENT January 2015 Page 1" |
|
| 08/11/2023 |
6-K
| Quarterly results |
| 08/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 08/04/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 08/02/2023 |
6-K
| Quarterly results |
| 07/06/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 06/13/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/19/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/15/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Company" or "IMC",
": 6",
"IM Cannabis” or the “Company”) is a British Columbia company operating in the international medical cannabis industry. The Company’s common shares trade under the ticker symbol “IMCC” on both the NASDAQ Capital Market and the Canadian Securities Exchange (“CSE",
"Review: I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended March 31, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performanc...",
"Review: : I have reviewed the interim financial report and interim MD&A of IM Cannabis Corp. for the interim period ended March 31, 2023. 2. No misrepresentations: Based on my knowledge, having exercised reasonable diligence, the interim filings do not contain any untrue statement of a material fact or omit to state a material fact required to be stated or that is necessary to make a statement not misleading in light of the circumstances under which it was made, with respect to the period covered by the interim filings. 3. Fair presentation: Based on my knowledge, having exercised reasonable diligence, the interim financial report together with the other financial information included in the interim filings fairly present in all material respects the financial condition, financial performa..." |
|
| 05/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Company" or "IMC") , an international medical cannabis company, is announcing that it has closed the previously announced securities for debt settlement transaction with L5 Capital Inc. , a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company. Pursuant to the Debt Settlement, the Company settled outstanding indebtedness of $838,776 through issuing 492,492 units at a price of US$1.25 per Unit. Each Unit consists of one common share of the Company and one Common Share purchase warrant (each, a "Warrant",
"CERTIFICATE OF COMPLIANCE",
"Material Change Report",
"Common Shares”) and 492,492 Common Share purchase warrants of the Company on May 5, 2023. The Common Shares and Warrants were issued as disclosed in the Company’s press release and Form 9 – Notice of Proposed Issuance of Listed Securities",
"Common Shares”) of IM Cannabis Corp. (the “Issuer" |
|
| 05/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 05/03/2023 |
6-K
| Quarterly results |
| 04/28/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"6-K",
"Company" or "IMC") , an international medical cannabis company, has agreed to a securities for debt settlement transaction with L5 Capital Inc. , a company wholly-owned and controlled by Marc Lustig, the executive chairman and a director of the Company. Pursuant to the Debt Settlement, the Company will settle outstanding indebtedness of $838,776 through the issuance of 492,492 units at a price of US$1.25 per Unit. Each Unit consists of one common share of the Company and one Common Share purchase warrant (each, a “Warrant",
"Form 9 - Proposed Issuance of Securities" |
|
| 04/14/2023 |
6-K
| Quarterly results |
| 04/04/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/29/2023 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
| 03/29/2023 |
6-K
| Quarterly results |
| 03/17/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/15/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 03/07/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/23/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/13/2023 |
6-K
| Quarterly results |
| 02/09/2023 |
6-K
| Quarterly results |
| 02/09/2023 |
6-K
| Quarterly results |
| 02/08/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/07/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/02/2023 |
6-K
| Quarterly results |
| 02/02/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/02/2023 |
6-K
| Quarterly results |
|
|
|